3QM-14854-46439
4 vaccinations
5 coded responses
33 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 190 / PA
- Registered
- 2021-04-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-10
Registered in v-safe
-
2021-04-10
Dose 1 — Pfizer-BioNTech
- 2021-04-10
- 2021-04-11
-
2021-04-12
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-13
-
2021-04-14
Health check-in — days 1–6 daily, dose 1Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-04-15
Health check-in — days 1–6 daily, dose 1Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-04-16
Health check-in — days 1–6 daily, dose 1Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-04-17
Health check-in — day 7, dose 1Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-04-24
-
2021-05-01
Dose 2 — Pfizer-BioNTech
- 2021-05-01
-
2021-05-02
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-05-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-05-05
-
2021-05-06
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-05-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-05-08
- 2021-05-16
- 2021-05-24
-
2021-05-29
Survey response — day 28, dose 2MedDRA: Polymorphic light eruption — Feeling: GoodFree text: Polymorphous light eruptionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-07
-
2021-06-13
Survey response — day 42, dose 2MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-31
Survey response — 3 months, dose 2MedDRA: Abortion spontaneous — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: MiscarriageMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-31
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-08-03
- 2021-10-30
-
2021-11-18
Dose 3 — Pfizer-BioNTech
-
2022-05-01
Survey response — 12 months, dose 2MedDRA: COVID-19, Pregnancy — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Pregnancy, COVIDMedDRA releases: 2024-11 · check-in free text available
-
2022-05-01
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-05-02
- 2022-05-19
-
2022-09-22
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-08
- 2022-10-13
- 2022-10-20
-
2022-10-27
Survey response — day 35, dose 4MedDRA: Nasopharyngitis, Respiratory tract congestion, Rhinorrhoea — Feeling: GoodFree text: Cold symptoms (runny nose, congestion)MedDRA releases: 2024-11 · check-in free text available
- 2022-11-03
- 2022-12-22
- 2023-03-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-10 | Pfizer-BioNTech | |
| 2 | 2021-05-01 | Pfizer-BioNTech | |
| 3 | 2021-11-18 | Pfizer-BioNTech | No |
| 4 | 2022-09-22 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-07-31 | Unsuccessful | |
| 2022-05-01 | Unsuccessful |
Free text
Release 8 — day 28, dose 2
Symptoms: Polymorphous light eruption
Release 9 — day 42, dose 2
Symptoms: Pregnancy
Release 9 — 3 months, dose 2
Symptoms: Miscarriage
Release 11 — 12 months, dose 2
Symptoms: Pregnancy, COVID
Release 12 — day 35, dose 4
Symptoms: Cold symptoms (runny nose, congestion)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | ✓ | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Polymorphic light eruption | ✓ | ✓ | ✓ |
| SD | Pregnancy | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release